This microRNA acts as a tumor suppressor in cervical cancer, by down-regulation of CHK1 (checkpoint kinase 1) gene (137) and up-regulation of aprataxin, which leads to radiosensitivity (138). The gene discussed is CHEK1; the disease is neoplasm.